Astellas Pharma News

Analysts Have Conflicting Sentiments on These Healthcare Companies: Astellas Pharma (OtherALPMF) and Verona Pharma (VRNA)

TipRanksJul 22 08:24 ET

Jefferies Downgrades Astellas Pharma (ALPMF) to a Hold

TipRanksJul 22 08:23 ET

Jefferies Downgrades Astellas Pharma to Hold From Buy, Adjusts Price Target to 1,700 Yen From 2,100 Yen

MT NewswiresJul 19 05:52 ET

Analysts' Top Healthcare Picks: Astellas Pharma (ALPMF), American Well (AMWL)

TipRanksJul 15 08:35 ET

Jefferies Adjusts Astellas Pharma's Price Target to 2,200 Yen From 2,400 Yen, Keeps at Buy

MT NewswiresDec 18, 2023 05:12 ET

Jefferies Upgrades Astellas Pharma to Buy From Hold, Keeps Price Target at 2,400 Yen

MT NewswiresOct 24, 2023 05:23 ET

Jefferies Adjusts Astellas Pharma's Price Target to 2,400 Yen From 2,300 Yen, Keeps at Buy

MT NewswiresMay 2, 2023 06:14 ET

Taysha Downgraded at Jefferies Citing Uncertain Outlook for Lead Asset

Seeking AlphaFeb 1, 2023 13:03 ET

Taysha Gene Therapies Downgraded to Neutral at Goldman Sachs on Measured Outlook

Seeking AlphaNov 9, 2022 11:57 ET